For patients with localized prostate cancer, stereotactic body radiotherapy (SBRT) offered comparable freedom from biochemical/clinical failure at eight years and nearly 40 percent lower urinary incontinence in comparison to radical prostatectomy, according to research presented at the ASTRO conference.
